Literature DB >> 17129298

NO pain: potential roles of nitric oxide in neuropathic pain.

Dan Levy1, Douglas W Zochodne.   

Abstract

The disabling human syndrome of "neuropathic pain" is an intractable complication of peripheral nerve injury or degeneration. A complex interaction between injured peripheral axons, sensory neurons and central nervous system signaling is thought to account for it. In this brief review, we present evidence that the free radical signaling molecule, nitric oxide (NO) may act at several levels of the nervous system during the development of experimental neuropathic pain. For example, NO may directly influence injured axons in the periphery, may indirectly influence pain by its role in the process of Wallerian degeneration, and may signal in the dorsal horn of the spinal cord. While it is premature to argue for therapeutic approaches that alter NO actions, it may be an important player in the cascade of events that generate neuropathic pain.

Entities:  

Year:  2004        PMID: 17129298     DOI: 10.1111/j.1533-2500.2004.04002.x

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  31 in total

1.  The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.

Authors:  Jenny L Wilkerson; Erin D Milligan
Journal:  ISRN Anesthesiol       Date:  2011

2.  Critical role of microglial CD40 in the maintenance of mechanical hypersensitivity in a murine model of neuropathic pain.

Authors:  Ling Cao; Christopher D Palmer; Jennifer T Malon; Joyce A De Leo
Journal:  Eur J Immunol       Date:  2009-12       Impact factor: 5.532

3.  Design, synthesis and biological evaluation of bivalent benzoxazolone and benzothiazolone ligands as potential anti-inflammatory/analgesic agents.

Authors:  Ahmed H Abdelazeem; Shabana I Khan; Stephen W White; Kenneth J Sufka; Christopher R McCurdy
Journal:  Bioorg Med Chem       Date:  2015-04-25       Impact factor: 3.641

Review 4.  Alcoholic neuropathy: possible mechanisms and future treatment possibilities.

Authors:  Kanwaljit Chopra; Vinod Tiwari
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

5.  Effect of dipyrone and thalidomide alone and in combination on STZ-induced diabetic neuropathic pain.

Authors:  Neha Chauhan; Rajeev Taliyan; Pyare Lal Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-17       Impact factor: 3.000

6.  Evaluation of ameliorative effect of quercetin in experimental model of alcoholic neuropathy in rats.

Authors:  Kiran S Raygude; Amit D Kandhare; Pinaki Ghosh; Arvindkumar E Ghule; Subhash L Bodhankar
Journal:  Inflammopharmacology       Date:  2012-02-14       Impact factor: 4.473

Review 7.  Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain.

Authors:  Abhilasha Ahlawat; Ajay Rana; Nidhi Goyal; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2014-08-06       Impact factor: 4.473

8.  Hyperpolarization-activated ion channels as targets for nitric oxide signalling in deep cerebellar nuclei.

Authors:  Gary W Wilson; John Garthwaite
Journal:  Eur J Neurosci       Date:  2010-06-01       Impact factor: 3.386

Review 9.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

10.  Leptin derived from adipocytes in injured peripheral nerves facilitates development of neuropathic pain via macrophage stimulation.

Authors:  Takehiko Maeda; Norikazu Kiguchi; Yuka Kobayashi; Toshihiko Ikuta; Masanobu Ozaki; Shiroh Kishioka
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.